Shanghai Green Valley launches brown algae-based Alzheimer’s drug

Bloomberg News reports that a newly approved Chinese drug for Alzheimer’s will start clinical trials in the U.S. and Europe this year as the country’s first novel therapy for the incurable disease seeks global legitimacy… [Read the full story]